Covestor’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Covestor's JAZZ Position: Q3 2026 in Review
Covestor increased its Jazz Pharmaceuticals (JAZZ) stake by 18% in Q3 2026, buying an estimated $5.93K and bringing the position to 155 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #889.
Covestor first reported a position in JAZZ in Q4 2021 and has held it in 20 quarters since. The position peaked at $145K in Q1 2025. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Covestor held 155 shares of Jazz Pharmaceuticals worth $36K as of Q3 2026.
- Covestor bought 24 Jazz Pharmaceuticals shares in Q3 2026, an estimated $5.93K.
- Jazz Pharmaceuticals made up 0.02% of Covestor's portfolio in Q3 2026, its #889 holding.
- Covestor first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- Covestor's Jazz Pharmaceuticals position peaked at $145K in Q1 2025.
- 538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.